Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | Milan | Healthcare | Pharmaceuticals | EUR 241.03B | 20.8x | -2.2 | EUR 95.20 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sanofi | Milan | Healthcare | Pharmaceuticals | EUR 114.74B | 25.5x | -0.49 | EUR 90.25 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gilead Sciences | Milan | Healthcare | Pharmaceuticals | EUR 111.06B | 920.8x | -9.28 | EUR 88.02 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merck | Milan | Healthcare | Pharmaceuticals | EUR 60.03B | 22.3x | -3.23 | EUR 136.15 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bayer | Milan | Healthcare | Pharmaceuticals | EUR 18.58B | -21.2x | -0.29 | EUR 18.96 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Recordati | Milan | Healthcare | Pharmaceuticals | EUR 10.28B | 24.5x | 1.93 | EUR 50.40 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.1% Upside | Upgrade to Pro+ | |
Pharmanutra | Milan | Healthcare | Pharmaceuticals | EUR 524.59M | 32.3x | 0.88 | EUR 54.60 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shedir Pharma | Milan | Healthcare | Pharmaceuticals | EUR 55.22M | 7.2x | -4.67 | EUR 4.86 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Laboratorio Farmaceutico Erfo | Milan | Healthcare | Pharmaceuticals | EUR 9.95M | 18.5x | -0.78 | EUR 1.25 | 6.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.6% Upside | Upgrade to Pro+ | |
Friulchem | Milan | Healthcare | Pharmaceuticals | EUR 5.28M | -16.8x | 0.01 | EUR 0.88 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.4% Upside | Upgrade to Pro+ |